Use of cDNA microarrays to estimate gene modulation profiles induced by zoledronic acid treatment in androgen-resistant prostate cancer cell line (PC3). Hematology Meeting Reports (formerly Haematologica Reports), [S. l.], v. 2, n. 3, 2009. DOI: 10.4081/hmr.v2i3.365. Disponível em: https://journals.pagepress.org/hmr/article/view/365. Acesso em: 20 jun. 2025.